BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27678454)

  • 1. Signal Transduction and Activator of Transcription-3 (STAT3) in Patients with Colorectal Cancer: Associations with the Phenotypic Features of the Tumor and Host.
    Park JH; van Wyk H; McMillan DC; Quinn J; Clark J; Roxburgh CS; Horgan PG; Edwards J
    Clin Cancer Res; 2017 Apr; 23(7):1698-1709. PubMed ID: 27678454
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical utility of the local inflammatory response in colorectal cancer.
    Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.
    Dobi E; Monnien F; Kim S; Ivanaj A; N'Guyen T; Demarchi M; Adotevi O; Thierry-Vuillemin A; Jary M; Kantelip B; Pivot X; Godet Y; Degano SV; Borg C
    Clin Colorectal Cancer; 2013 Mar; 12(1):28-36. PubMed ID: 23083634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RING-Finger Protein 6 Amplification Activates JAK/STAT3 Pathway by Modifying SHP-1 Ubiquitylation and Associates with Poor Outcome in Colorectal Cancer.
    Liang Q; Ma D; Zhu X; Wang Z; Sun TT; Shen C; Yan T; Tian X; Yu T; Guo F; Tang J; Lin Y; Chen H; Zhou C; Ge Z; Zhong M; Chen J; Liu Q; Wang Z; Fang JY; Chen H; Hong J
    Clin Cancer Res; 2018 Mar; 24(6):1473-1485. PubMed ID: 29288235
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
    Pennel KAF; Hatthakarnkul P; Wood CS; Lian GY; Al-Badran SSF; Quinn JA; Legrini A; Inthagard J; Alexander PG; van Wyk H; Kurniawan A; Hashmi U; Gillespie MA; Mills M; Ammar A; Hay J; Andersen D; Nixon C; Rebus S; Chang DK; Kelly C; Harkin A; Graham J; Church D; Tomlinson I; Saunders M; Iveson T; Lannagan TRM; Jackstadt R; Maka N; Horgan PG; Roxburgh CSD; Sansom OJ; McMillan DC; Steele CW; Jamieson NB; Park JH; Roseweir AK; Edwards J
    J Exp Clin Cancer Res; 2024 Mar; 43(1):64. PubMed ID: 38424636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
    Wu ZS; Cheng XW; Wang XN; Song NJ
    Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
    Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
    Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer.
    Park JH; McMillan DC; Powell AG; Richards CH; Horgan PG; Edwards J; Roxburgh CS
    Clin Cancer Res; 2015 Feb; 21(4):882-8. PubMed ID: 25473000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of SOCS3 and its biological function in colorectal cancer.
    Chu Q; Shen D; He L; Wang H; Liu C; Zhang W
    Gene; 2017 Sep; 627():114-122. PubMed ID: 28603075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer.
    Richards CH; Roxburgh CS; Anderson JH; McKee RF; Foulis AK; Horgan PG; McMillan DC
    Br J Surg; 2012 Feb; 99(2):287-94. PubMed ID: 22086662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas.
    Paik JH; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
    BMC Cancer; 2014 Dec; 14():911. PubMed ID: 25472725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
    Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
    Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
    van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
    Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of pSTAT3 in human colorectal carcinoma: correlation with clinico-pathological parameters.
    Zizi-Sermpetzoglou A; Savvaidou V; Myoteri D; Rizos S; Marinis A
    J BUON; 2012; 17(4):691-4. PubMed ID: 23335526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.
    Aleskandarany MA; Agarwal D; Negm OH; Ball G; Elmouna A; Ashankyty I; Nuglozeh E; Fazaludeen MF; Diez-Rodriguez M; Nolan CC; Tighe PJ; Green AR; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2016 Feb; 156(1):9-20. PubMed ID: 26907764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer.
    Park JH; van Wyk H; Roxburgh CSD; Horgan PG; Edwards J; McMillan DC
    Br J Cancer; 2017 May; 116(11):1444-1450. PubMed ID: 28427085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
    Lee J; Kang WK; Park JO; Park SH; Park YS; Lim HY; Kim J; Kong J; Choi MG; Sohn TS; Noh JH; Bae JM; Kim S; Lim DH; Kim KM; Park CK
    APMIS; 2009 Aug; 117(8):598-606. PubMed ID: 19664131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
    Jensen TO; Schmidt H; Møller HJ; Donskov F; Høyer M; Sjoegren P; Christensen IJ; Steiniche T
    Cancer; 2012 May; 118(9):2476-85. PubMed ID: 21953023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.